Frederick, MD, United States of America

Cristina Bergamaschi

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Cristina Bergamaschi: Innovator in Immunology

Introduction

Cristina Bergamaschi is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of immunology, particularly in the development of therapies aimed at enhancing thymic output and treating lymphopenia. With a total of five patents to her name, her work is paving the way for advancements in immune system therapies.

Latest Patents

Among her latest patents, Cristina has developed methods involving heterodimers of IL-15 and IL-15R alpha to increase thymic output and treat lymphopenia. The present invention provides a method for promoting the maturation and export of T cells from thymic tissue by contacting the thymic tissue with supraphysiological levels of interleukin (IL)-15. Additionally, her inventions include methods for preventing, alleviating, reducing, and/or inhibiting lymphopenia or peripheral depletion of lymphocytes in patients by administering IL-15.

Career Highlights

Cristina Bergamaschi is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on groundbreaking research that has the potential to transform patient care in immunology.

Collaborations

Cristina has collaborated with notable colleagues in her field, including George N Pavlakis and Barbara K Felber. These collaborations have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Cristina Bergamaschi's contributions to immunology through her patents and research at the National Institutes of Health highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapies for immune-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…